Clindac A Gel (Clindamycin + Nicotinamide) – Hobart, Tasmania, Australia (2026)
Visit
Website: unnatipharmax.com
Phone: +91 82650 41513
Email: Unnatipharmax@gmail.com
PRODUCT NAME
Brand Name: Clindac A Gel
Generic Name: Clindamycin Phosphate + Nicotinamide Gel
Dosage Form: Topical Gel
Therapeutic Category: Topical Antibiotic & Anti-Inflammatory Acne Treatment
PRODUCT DETAILS
Clindac A Gel combines Clindamycin Phosphate, a topical antibiotic, with Nicotinamide (Niacinamide), an anti-inflammatory ingredient to help manage acne vulgaris. The combination works by reducing acne-causing bacteria, decreasing inflammation, and helping improve the appearance of acne-prone skin.
It may be prescribed for:
- Acne Vulgaris
- Inflammatory Acne
- Papules and Pustules
- Facial Acne
- Oily & Acne-Prone Skin
- Mild to Moderate Acne
Use only as directed by a qualified healthcare professional. To help reduce the risk of antibiotic resistance, topical antibiotics are commonly prescribed as part of a broader acne treatment plan.
PRODUCT SPECIFICATION
| Brand Name | Clindac A Gel |
| Generic Name | Clindamycin Phosphate + Nicotinamide |
| Dosage Form | Topical Gel |
| Route | External Use Only |
| Therapeutic Class | Topical Antibiotic + Anti-Inflammatory |
| Packaging | Tube |
| Storage | Store below 25°C in a cool, dry place |
| Prescription | May be required depending on local regulations |
| Manufactured In | India |
| Export Availability | Worldwide (where legally permitted) |
KEY FEATURES
- Contains Clindamycin Phosphate and Nicotinamide
- Dual-action topical gel for acne management
- Helps reduce acne-causing bacteria
- Assists in reducing redness and inflammation
- Smooth, non-greasy gel formulation
- Manufactured in WHO-GMP compliant facilities
- Quality-assured pharmaceutical product
- Secure packaging for international export
- Available for retail, wholesale, and bulk supply
- Competitive export pricing
INDUSTRY UPDATE (2026)
The global dermatology market continues to grow in 2026, supported by increasing awareness of acne management and wider access to dermatology services. Combination topical therapies containing antibiotics and anti-inflammatory agents remain commonly prescribed for selected patients with inflammatory acne.
Current market trends include:
- Increased emphasis on evidence-based acne treatment
- Responsible use of topical antibiotics to support antimicrobial stewardship
- Growing demand for quality-assured generic dermatology products
- Expansion of teledermatology and virtual skin consultations
- Continued investment in pharmaceutical manufacturing quality, regulatory compliance, and international distribution of dermatology medicines

FAQ 1: How does Tasmania's unique demographic — Australia's most aged population — create adult-onset acne patterns that Clindac A Gel addresses?

FAQ 2: How does Hobart's famous food and whisky culture — highlighted in the Rompag blog — interact with acne and Clindac A Gel use?

FAQ 3: How does Tasmania's limited specialist dermatology access affect Clindac A Gel prescribing for Hobart's acne patients?

FAQ 4: How should Clindac A Gel be integrated into a complete acne treatment regimen for Hobart patients?

FAQ 5: What is the PBS pathway for Clindamycin topical in Australia and how does Clindac A Gel from Unnati Pharmax complement it?
Website
Email Id
Contact Number
+91-8265041513